Wir sind mit live! Mehr erfahren

Veeva Systems

VEEV

Börsenwert 50,3 Mrd. $

310,36 USD

-2,67

0,85 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

310,36

0,00

0 %

1 Tag

-0,85 %

5 Tage

4,66 %

1 Monat

17,16 %

3 Monate

57,25 %

6 Monate

85,08 %

Seit Jahresbeginn

41,4 %

1 Jahr

6,02 %

5 Jahre

-0,04 %

10 Jahre

717,38 %

Profil: Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Mitarbeiter: 7.928

Gesundheitswesen Gesundheitsinformationsdienste

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 54,9 %

Neutral 37,8 %

Negativ 7,3 %

Zacks Investment Research

Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?

Zacks Investment Research

Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know

Veeva to Host Virtual Investor Day on November 5, 2026

PLEASANTON, Calif., Oct. 14, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, November 5, 2026.

Veeva to Host Virtual Investor Day on November 5, 2026

Investors Business Daily

Veeva Stock Breaks Out As Big Money Grabs Exposure To The AI Software Play

Veeva Systems stock moves above a buy point in its early-stage chart pattern.

Veeva Stock Breaks Out As Big Money Grabs Exposure To The AI Software Play

Zacks Investment Research

VEEV Expands IQVIA Partnership With Clinical Operations Software Suite

Veeva expands its IQVIA partnership with clinical operations software, boosting its market reach and growth prospects through wider adoption and integrated workflows.

VEEV Expands IQVIA Partnership With Clinical Operations Software Suite

Zacks Investment Research

Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know

Veeva Systems (VEEV) reached $301.63 at the closing of the latest trading day, reflecting a +1.95% change compared to its last close.

Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know

Zacks Investment Research

Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms

VEEV's push into early-stage biotech could unlock long-term revenue opportunities as its streamlined software solutions simplify critical drug development processes.

Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms

IQVIA Selects Veeva Clinical Operations Applications

RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif.

IQVIA Selects Veeva Clinical Operations Applications

Zacks Investment Research

Reasons to Hold Veeva Systems Stock in Your Portfolio for Now

VEEV's strong second-quarter results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.

Reasons to Hold Veeva Systems Stock in Your Portfolio for Now

Wall Street Left Software for Dead: 4 Stocks Institutions Are Buying Back

Software opened the year as the market's favorite casualty. The SPDR S&P Software & Services ETF NYSEARCA: XSW and the iShares Expanded Tech-Software Sector ETF BATS: IGV each dropped roughly 25% to 27% in the first quarter alone, as traders priced in a future where artificial intelligence (AI) made subscription software obsolete.

Wall Street Left Software for Dead: 4 Stocks Institutions Are Buying Back

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt